As of August 14, 2026, AbCellera Biologics Inc. (ABCL) has a DilutionWatch DilutionScore of 35/100, rated MEDIUM dilution risk. AbCellera Biologics Inc. has 306.61M shares outstanding, 140 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Score Breakdown
🔄Convertible Debt—
Dilution Forecast
☀️
Clear
No significant dilution signals
7%
💰 Capital Raise
15%
• Under 12 months cash (11mo)
Market Data
Market CapN/A
Shares Outstanding306.61M
Float206.94M
Cash$120.06M
Debt$190.0K
Short InterestN/A
Institutional Holdings
QoQ: ↑ 31.4% shares (2026Q1 vs prior)
140 institutional holders · 142.73M shares
#1
BAKER BROS. ADVISORS LP
30.28M shares
#2
Capital World Investors
13.36M shares
#3
TWO SIGMA INVESTMENTS, LP
10.56M shares
Short Interest
Short Interest48.32M
Days to Cover9.7
% of Float23.4%
FINRA data as of Jul 31, 2026
Recent SEC Activity
No recent SEC insights
Recent News
No recent news
Track ABCL Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ABCL — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for ABCL
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.